BPC 157 Dosing (Common Protocols), Oral Subcutaneous, 500 mcg daily, Duration: 6 weeks, Intramuscular Peritendinous, 1 mg daily, Duration: 6 weeks, Note:, Not approved by FDA or Sample of patents with BPC 157 utilization. Download Scientific Diagram Evexias BPC 157 If you want the full protocol for BPC157, reply with BPCPRO and I will send it directly to your DMs., BPC157 Oral Arginate Salt has been a game changer for so many of our patients and in my own